Drugmakers in the red, as CMS releases its drugs that are subject to medicare price negotiations. The names getting hit the hardest, and how its impacting the weight loss drug race. Plus Is Intel on the market? M&A rumors helping boost the stock, but who could be the buyer? What a deal could mean for the beaten down chipmaker, and the impact on the tech space. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
Apple’s decline continues as iPhone sales in China plunge for its worst yearly decline ever. And with tariffs dangling overhead, could there be even more trouble ahead for the tech giant. Plus A Bitcoin Bond ETF the latest addition to the crypto craze. What it is, and how proxies like MicroStrategy play a role in its performance. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
Bank stocks surging as the group kicks off earnings season on a positive note. How their financials are faring, and the setup for the rest of earnings. And It wasn’t just the banks in the green. Stocks surging across the board as core inflation slows in December. What the data means for the central bank’s next move, as we count down to another Fed rate decision. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
Shares of Eli Lilly taking a hit, as the pharma giant cuts its sales outlook. But could the dip be a buying opportunity? The latest out of JP Morgan’s Health Care Conference in San Francisco. And speaking of JP Morgan… the big bank and its peers kicking off earnings season tomorrow. What to expect from those results and why one top bank analyst says it’s all about the yield curve for the group. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
Some of the most popular names in the market seeing some major moves. How the recent drops in Nvidia, Tesla, and Bitcoin fare from here, and how banks are setting up ahead of earnings season. Plus The prognosis on the health care space, as the industry’s top execs convene at the JPMorgan conference in San Francisco. How our traders are handling the moves in the space’s biggest names. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
Stocks selling off as investors digested this morning’s stronger than expected jobs report. And with nearly all of the post-election gains fading, with next week’s inflation data cause even more volatility? Plus Obesity drugs expected to be in focus at this year’s JPMorgan Health Care conference. How the industry’s biggest names are handling competition, and the next-generation of weight loss drugs. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
Rates on the rise, as investors brace for what President-elect Donald Trump’s tariff plan could do to inflation. The trouble brewing under the surface.. And the sections of the market feeling the pressure. And A check on the middle market. What a new report out of a private credit powerhouse is saying about the landscape. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
Meta scrapping its third-party fact-checking program, as the social giant moves closer towards an ‘X’ style platform. Why CEO Mark Zuckerberg is calling the recent election a ‘tipping point’ for the move, and how users will respond to the changes. Plus From Leaders to laggards. Why Katie Stockton sees big opportunity in some beaten down spaces as a rotation gets underway. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
Shares of Nvidia closing at a record high, as CEO Jensen Huang gets ready to take the stage at the Consumer Electronics Show in Las Vegas. What he’ll say about the company’s next move, and if this stock can keep hitting records. Plus President-elect Donald Trump reportedly changing his tune on tariffs. The stocks seeing the biggest impact, and the inflation risk that comes with a universal tariff. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
Markets closing out the week with a bang, as the S&P 500 and Nasdaq snap 5 day losing streaks. What the start of January could say about 2025 trading, and the latest comments from one Federal governor. Plus China targeting dozens of U.S. companies with new sanctions.The impact on markets, and what it means for U.S.-China relations. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
The new year kicking off with a Magnificent 7 Meltdown, with Apple leading the losses. How the decline brought down the broader market on the first trading day of 2025, and what it could say about how stocks will fare the rest of the year. Plus Mortgage demand dropping to close out 2024. Why buyers are staying on the sidelines, and what it means for the homebuilder stocks. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
A big 2024 for stocks as the S&P 500 notches it’s best 2-year gain since 1998. And with the MAG7 stocks doing most of the heavy lifting, will tech continue to carry the weight in 2025? Plus Global opportunities in the new year. Where your money could do the most traveling, and the markets that could ring in the new year with some strong growth. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
CNBC's Tanaya Macheel speaks with Zach Pandl, Managing director of research for Grayscale, to break down the cryptocurrency market's explosive 2024. Pandl also shares what thinks could drive digital asset prices even higher in 2025 and takes questions from Pro subscribers.
Stocks paring early losses but still closing in the red, and with just one trading day left in 2024, the supposed Santa Claus rally seems virtually out of reach. So will stocks start the new year with the same lump of coal? Plus The potential impact from the Bird Flu virus. What we know, and what an outbreak could mean for millions of Americans. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
Markets still searching for a Santa Claus rally, as stocks sell off to close out the week. And with just a few days left to go in 2024, are markets setting up for a painful start to the new year? Plus How you should play 2024’s biggest gainers and laggards. The traders make their picks with a good old fashioned game of “Trade It or Fade It”. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
Shares of Apple at record highs, and nearing a major milestone. What the elusive $4 trillion market cap means for the tech giant, and if the stock can keep climbing in 2025. Plus Netflix’s Christmas Day NFL double feature. How the live games fared over the holidays, and what it means for a potential ad-tier. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
Consumer staples stocks struggled on an otherwise strong day for markets, as yields and the dollar rose. What’s that say about the strength of stocks in the new year? Plus semis surge on a new probe into China’s chip industry, Zillow lays out its forecast for housing in 2025, and what to expect from FinTech and M&A. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
Stocks bouncing back after a rough week, as investors digest encouraging inflation data, as well as dovish rate commentary from Chicago Fed President Austan Goolsbee. So could a Santa Claus rally still be in the cards? Plus 2024 nearing an end, and it’s been a big year for stocks. And our traders are picking out the one chart that blew them away. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
Two big risks facing the market, as rates and the dollar both continue to climb. What the rise means for equities, and where the 10-year yield is heading from here. Plus A slew of health care headlines impact the space. The pressure on insurers, a weight-loss shortage update, and the disappointing study results pushing one pharma stock lower. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
Stocks selling off after the Federal Reserve slashed interest rates by a quarter point. Why Powell is indicating less rate cuts in 2025… and what it means for markets. Plus the momentum trades losing a ton of steam late in the day. What it all means for stocks into year-end. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
Could the 10-year yield climb as high as 6%? The bold rate call out of one Wall Street firm, and what it would mean for this year’s rally. Plus A new funding round from one of the most valuable private companies, and what the CEO says could be next for the AI startup. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
Bitcoin hitting another record high, as MicroStrategy jumps on news it will be added to the Nasdaq 100. Why the CEO is calling the crypto a “cyber Manhattan”, and the price tag he’s putting on Bitcoin. Plus Markets hovering near record highs, and Wall Street expectations are for another solid year. But could the new year ring in a 10% sell off? How one market strategist is forecasting 2025. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
A rough prognosis for the health care sector, as new reports about RFK Jr’s allies point to a major overhang for vaccine makers. How names like Pfizer, Morderna, and Sanofi will fare under the new administration, as the entire health space comes into focus. Plus One more rate decision before the new year… and with expectations of another cut, could the Fed’s easing cycle be nearing an end? How next week’s rate decision will impact markets going into year end. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
Another record close for Apple as the tech titan’s rally continues. The driving factors behind those gains, as the company’s market cap nears the $4 trillion mark. Plus Make Crypto Great Again? President-Elect Donald Trump weighing in on the crypto space as Bitcoin hovers near $100K. The future of crypto under Trump, and why the founder of the world’s first institutional Bitcoin fund says the rally is just getting started. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
The Nasdaq reaching new heights, as the index surpasses 20,000 for the first time ever. The tech surge that brought it there, and if the rally has more room to run. Plus Nuclear energy taking off, as power hungry AI data centers drive fuel demand. An inside look at one uranium mine in Canada that’s 1600 feet underground. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
Shares of Alphabet surging as Google unveils a ‘breakthrough’ quantum computing chip. What it means for the future of coding, and the areas of tech that could benefit. Plus A spotlight on the health insurance space, as the suspect in the UNH CEO murder investigation heads to his first court appearance. The latest details on his motives, and how it could all impact other players in the health insurance space. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
Some of this year’s hottest stocks staging a major reversal to start the week. The Tech, restaurants, and asset manager stocks in the red, and if there’s more pain to come. Plus Major developments in the UnitedHealthcare CEO’s murder investigation, and the slaying has the whole insurance space under a spotlight. How AI may be behind a slew of claim denials… and what it means for the future of the industry. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
Social stocks gaining momentum as an appeals court upholds the law requiring a ban or sale of TikTok. What it means for the likes of Meta and Snap… and when the social media platform could get blocked. Plus UNH notches its worst week since before the pandemic. The fallout from the company’s CEO’s murder… and how the company will move forward from here. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
All eyes on tomorrow’s November jobs report, as stocks take a breather from their recent rally. The pockets of strength in today’s trading, and what tomorrow’s employment data could mean for the markets next move. Plus Bitcion finally breaking through the elusive $100,000 level. What the milestone means for the crypto space, and where retail investors are putting their money to work. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/
Big tech taking the lead, and driving the S&P 500 and Nasdaq to fresh record highs. How semis, software, and other sections of the tech trade can fuel your portfolio. Plus Fast Money’s Obesity Week coverage continues. Eli Lilly’s Chief Scientific Officer breaks down how the company’s obesity drug Zepbound performed in its first head-to-head clinical trial against Novo’s Wegovy, and what the results could mean for the weight loss drug wars. FAST MONEY DISCLAIMER https://www.cnbc.com/fast-money-disclaimer/